1. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders;Kunishima;Blood J Am Soc Hematol,2008
2. Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion;Léon;Blood J Am Soc Hematol,2007
3. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway;Chen;Blood J Am Soc Hematol,2007
4. Clinical and molecular genetic analysis of a family with macrothrombocytopenia and early onset sensorineural hearing loss;Mhatre;Eur J Med Genet,2009
5. Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice;Matsushita;Biochem Biophys Res Commun,2004